Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks [Yahoo! Finance]
Insmed, Inc. (INSM)
Last insmed, inc. earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Yahoo! Finance
Insmed (INSM) revenue surged 52.36% year-over-year in Q3 2025. The stock climbed from $25 to $189 since Q2 2024. Teva (TEVA) has rallied over 300% since June 2023. Druckenmiller accumulated shares every quarter from Q3 2024 to Q3 2025. If you're thinking about retiring or know someone who is, there are three quick questions causing many Americans to realize they can retire earlier than expected. take 5 minutes to learn more here Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been winning. He has been piling into Natera ( NASDAQ:NTRA Insmed ( NASDAQ:INSM , and Teva Pharmaceuticals ( NYSE:TEVA as of late, and we'll get into why. Druckenmiller first gained fame by managing George Soros's Quantum Fund, where he orchestrated the $10 billion currency bet that "broke the Bank of England" in 1992. Since founding Duquesne Capital Management in 1981, he's delivered annualized returns exceeding 30% before closing to out
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed, Inc. news events
Weekly update
A roundup of the hottest topics
INSM
News
- Insmed (INSM): Assessing Valuation After a Strong Year of Share Price Gains [Yahoo! Finance]Yahoo! Finance
- Is It Too Late to Consider Insmed After a 179% Surge and DCF Upside? [Yahoo! Finance]Yahoo! Finance
- Insmed (NASDAQ:INSM) had its price target raised by analysts at TD Cowen from $231.00 to $269.00. They now have a "buy" rating on the stock.MarketBeat
- Questex's Chief Medical Officer Summit 360° Announces 2026 Agenda and Keynotes [Yahoo! Finance]Yahoo! Finance
- Insmed (NASDAQ:INSM) was given a new $269.00 price target on by analysts at Jefferies Financial Group Inc..MarketBeat
INSM
Earnings
- 10/30/25 - Miss
INSM
Sec Filings
- 12/9/25 - Form 4
- 12/5/25 - Form 144
- 12/5/25 - Form 4
- INSM's page on the SEC website